Cronos (CRON) Divestments (2022 - 2023)
Cronos' (CRON) quarterly Divestments came in at -$4000.0 in Q4 2023, down 300.0% quarter-over-quarter from $2000.0 in Q3 2023.
Cronos (CRON) Divestments (2022 - 2023) Analysis & Trends
Cronos' Divestments history runs 2 years deep, the most recent figure standing at -$4000.0 for Q4 2023.
- On a quarterly basis, Divestments changed N/A year-over-year to -$4000.0 in Q4 2023; TTM through Dec 2024 was -$2000.0, a 0.0% change from a year earlier, with the FY2023 full-year figure at $1.3 million, changed N/A from the prior year.
- Divestments declined to -$4000.0 in Q4 2023 per CRON's latest filing, from $2000.0 in the prior quarter.
- Across five years, Divestments topped out at $44000.0 in Q1 2022 and bottomed at -$44000.0 in Q2 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Divestments (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 42.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 3.28 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 63.20 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Cronos | 1.04 Bn | 267.78 Mn | 19.15 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | -4,000.00 |
| Sep 30, 2023 | 2,000.00 |
| Jun 30, 2022 | -44,000.00 |
| Mar 31, 2022 | 44,000.00 |